US EditionPublished • loading... • Updated
NanoTess lands Embecta deal to put its tech in 14,000 Canadian pharmacies
Summary by BetaKit
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
NanoTess lands Embecta deal to put its tech in 14,000 Canadian pharmacies
Calgary startup NanoTess has signed a distribution deal with diabetes care company Embecta, bringing its flagship product to more than 14,000 pharmacies across Canada. “NanoSALV focuses on addressing the root cause of biochemical stagnation, enabling stalled healing processes to begin again.” Megan Leslie, NanoTess NanoTess, which develops technology to treat chronic wounds, announced the partnership with Embecta on Tuesday that will see Embect…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
